$CHCT

Community Healthcare Trust Inc (CHCT): Results of Operations and Financial Condition

Community Healthcare Trust Inc (CHCT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2026 FRANKLIN, Tenn., August 4, 2026 / PRNewswire / -- Community Healthcare Trust Incorporated (NYSE: CHCT ) (the "Company") today announced results for the three months end

Original reporting
Published Aug 4, 2026, 8:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CHCT
Bullish
medium confidence
Mentioned
$CHCT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CHCTBullishMed
01

Why it matters

The disclosure updates quarterly operating performance (revenues, NOI, FFO, AFFO) and balance-sheet/capitalization metrics (net debt, debt-to-capitalization, interest-rate assumptions), which can affect valuation and dividend sustainability expectations.

02

Market read

Traders can use the updated 2Q 2026 NOI, FFO, AFFO, and leverage/interest-rate disclosures to reassess near-term valuation and risk, though no new guidance or transaction is shown in the excerpt.

03

What to watch

The excerpt highlights hedged term-loan rates and debt-to-capitalization, but does not show maturity/refinancing schedule changes or tenant-level credit events, which could be the real driver of risk pricing.

Relevance 7/10Novelty 6/10Timing: filed after market close, for next-session positioning

Background

Community Healthcare Trust Inc (CHCT) submitted an SEC 8-K for Item 2.02, attaching 2Q 2026 supplemental financial information.

Company-level read

Ticker impact

$CHCTBullishMedium confidence
Context

CHCT filed an 8-K with 2Q 2026 operating results and financial condition, including NOI, FFO/AFFO, and balance-sheet leverage metrics.

Expected impact

Near-term trading bias modestly positive if investors view FFO/AFFO and NOI stability as supportive, but magnitude likely limited because this is a routine quarterly disclosure.

Evidence & confidence

The filing provides detailed quarterly income and REIT operating metrics (NOI, FFO, AFFO) plus capitalization and interest-rate hedging context (debt to total cap, hedged term-loan rate). No guidance change, deal, or regulatory event is included in the provided excerpt.

Market effects

Adds incremental datapoints on community healthcare REIT operating performance, leverage, and hedged borrowing costs that can influence sector read-across for similar healthcare landlords.

No specific regional demand or tenant-credit shock is disclosed in the excerpt.

Limited global relevance; this is company-specific REIT financial reporting.

Counterpoint

Net income is volatile for REITs due to impairment and sale-related items; investors may discount it versus recurring NOI/FFO and focus on balance-sheet net debt trends.

Key entities

  • Community Healthcare Trust Inc

    Subject of the 8-K, providing 2Q 2026 results and financial condition supplemental tables.

  • CHCT

    Common stock referenced in the filing, including quarter-end stock price and dividend per share.

Related articles

$CHCTMed

Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2026

Community Healthcare Trust Inc. (NYSE: CHCT) reported net income of about $2.4 million, or $0.06 per diluted share, for the three months ended June 30, 2026. FFO and AFFO were $0.48 and $0.56 per diluted share. The board cut the quarterly dividend to $0.33 per share, payable Aug. 31, 2026. CHCT also outlined occupancy, capital recycling, and acquisition pipeline plans.

$WDAYMedAI 8/10

Workday earnings analysis: questions answered and next catalysts

Workday (WDAY) reported Q2 FY2027 earnings beating revenue ($2.65B) and EPS ($2.75) estimates, but Q3 cRPO guidance (11-12%) missed expectations. AI products reached $600M ARR, up 200% YoY, while margins expanded to 31.1%. The company completed a $5B share buyback and authorized a new $4B program. Management did not address acquisition rumors. Next catalysts include Q3 earnings, potential Silver Lake deal, and AI monetization progress.

$RBRKHighAI 8/10

Rubrik earnings analysis: questions answered and next catalysts

Rubrik (RBRK) reported Q2 FY2027 earnings with EPS of $0.20 (vs. $0.04 expected) and revenue of $427.3M (vs. $396.3M forecast), but shares fell 10.4% due to slower-than-expected cloud ARR growth. Subscription ARR grew 33% YoY, while cloud net new ARR grew 20%. Management highlighted Identity Resilience as a growth driver and confirmed no ARR contribution from the Strata acquisition. Free cash flow rose to $65.7M, and profitability targets were reaffirmed. Analysts remain bullish, with a mean pri

$SMedAI 8/10

SentinelOne earnings analysis: questions answered and next catalysts

SentinelOne reported Q2 FY2027 revenue of $292M, beating estimates, with a record 10% operating margin. However, Q3 EPS guidance of $0.08–$0.09 missed consensus. The stock dropped 6.7%. Analysts are split, with some highlighting strong ARR growth and others citing valuation concerns. Next catalysts include Q3 earnings and AI security monetization.

$MRVLHighAI 9/10

Marvell Technology earnings analysis: questions answered and next catalysts

Marvell Technology (MRVL) reported Q2 FY2027 earnings, beating EPS and revenue estimates. Despite this, shares fell 8.2% due to high expectations. Data center revenue grew 27% YoY, driven by AI and cloud computing. The company secured a $120B deal with Google and maintained strong margins. Guidance for Q3 was above consensus, but analysts noted the stock's recent rally. Next catalysts include Q3 earnings, optical product ramps, and acquisitions. MRVL trades at 29x CY2028 earnings, with a PEG rat

$CRMHighAI 9/10

Cramer Says the Bears Spent Months Lying About Salesforce and Nvidia. One Earnings Report Just Ended It.

Salesforce (CRM) rose 23% after reporting strong seat growth and low attrition, with Agentforce ARR up 240% to $1.5B. NVIDIA (NVDA) guided Q3 revenue to $108B, exceeding estimates. Jim Cramer argued bearish theses on both companies were refuted by earnings. Salesforce reported $11.35B revenue and raised FY27 guidance. NVIDIA's Q2 revenue was $96.22B, up 105.85% YoY, with Q3 guidance at $108B.